- Contrary to previous beliefs, treatment can world in developing settings. (look at Brazil, Cuba etc.)
- It allows countries to build up their infrastructures (through additional foreign and humanitarian aid) and can provide models of care for other diseases
- Relieves the suffering of thousands, and is the morally and ethically appropriate thing to do.
And who can argue against the ethical argument?
However, for the next 50 or so pages D'Adesky highlights the barriers to care...
- adverse affects
- multi Drug Resistant-HIV
- costs of second-line therapies
- lack of food, resulting in difficulty swallowing ARV medications
- lack of clean water sources
- adherence issues, namely cost of medications
- superinfection (when an HIV positive person develops a more powerful, resist strain of HIV
- other Opportunistic Infections's (TB, Malaria, etc.) that can interfere with ARV regimens
- difficulties associated with treating children, women, and hard to reach population such as drug users.
- potential development of new not treatable strains of virus
- complicated training and human resource issues (medical literacy, different drug regimens etc.)
- ethical issues associated with research
No comments:
Post a Comment